In all glioma patients, we observed a positive correlation of percentage of CD14+ TREM-1+ cells with the IL-6/IL-10 ratio (P = 0.007) and a negative correlation with the plasma levels of IL-10 (P < 0.0001). The gene discussed is IL6; the disease is central nervous system cancer.